AFP and DCP are, however, the most useful serum tumor markers for detection of HCC, and the simultaneous determination of these markers might improve the accuracy, especially in differentiating HCC from precancerous lesions, and nonmalignant hepatopathy. This evidence concerns the gene ACE and hepatocellular carcinoma.